Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

Terminated 11 enrolled University of Wisconsin, Madison Novartis Pharmaceuticals · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether long-term maintenance therapy with a single drug (Myfortic) applied using advanced immunologic monitoring tools in selected patients can lead to superior native kidney function at 2 years without resulting in increased acute rejection episodes or deterioration of liver allograft function.

Timeline

Start: 2011-11
Primary completion: 2012-05
Completion: 2012-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	—	—
Subject	mycophenolic acid	Small molecule	720 mg	—

Indications

No indication recorded.